|
1
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Incassati A, Chandramouli A, Eelkema R and
Cowin P: Key signaling nodes in mammary gland development and
cancer:β-catenin. Breast Cancer Res. 12:2132010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smalley MJ and Dale TC: Wnt signalling in
mammalian development and cancer. Cancer Metastasis Rev.
18:215–230. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nusse R and Varmus HE: Many tumors induced
by the mouse mammary tumor virus contain a provirus integrated in
the same region of the host genome. Cell. 31:99–109. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Hively WP and Varmus HE: Use of
MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast
cancer. Oncogene. 19:1002–1009. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scheel C, Eaton EN, Li SH, Chaffer CL,
Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL and
Weinberg RA: Paracrine and autocrine signals induce and maintain
mesenchymal and stem cell states in the breast. Cell. 145:926–940.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bafico A, Liu G, Goldin L, Harris V and
Aaronson SA: An autocrine mechanism for constitutive Wnt pathway
activation in human cancer cells. Cancer Cell. 6:497–506. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim
NH, Cha SY, Ryu JK, Choi YJ, Kim J, et al: A Wnt-Axin2-GSK3beta
cascade regulates Snail1 activity in breast cancer cells. Nat Cell
Biol. 8:1398–1406. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG and
Weiss SJ: Canonical Wnt signaling regulates Slug activity and links
epithelial-mesenchymal transition with epigenetic breast cancer 1,
early onset (BRCA1) repression. P Natl Acad Sci USA.
109:16654–16659. 2012. View Article : Google Scholar
|
|
11
|
Cruciat CM and Niehrs C: Secreted and
transmembrane wnt inhibitors and activators. Cold Spring Harb
Perspect Biol. 5:a0150812013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimomura Y, Agalliu D, Vonica A, Luria V,
Wajid M, Baumer A, Belli S, Petukhova L, Schinzel A, Brivanlou AH,
et al: APCDD1 is a novel Wnt inhibitor mutated in hereditary
hypotrichosis simplex. Nature. 464:1043–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takahashi M, Fujita M, Furukawa Y,
Hamamoto R, Shimokawa T, Miwa N, Ogawa M and Nakamura Y: Isolation
of a novel human gene, APCDD1, as a direct target of the
beta-Catenin/T-cell factor 4 complex with probable involvement in
colorectal carcinogenesis. Cancer Res. 62:5651–5656.
2002.PubMed/NCBI
|
|
14
|
Mathelier A, Zhao X, Zhang AW, Parcy F,
Worsley-Hunt R, Arenillas DJ, Buchman S, Chen CY, Chou A, Ienasescu
H, et al: JASPAR 2014: An extensively expanded and updated
open-access database of transcription factor binding profiles.
Nucleic Acids Res. 42:(Database issue). D142–D147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Messeguer X, Escudero R, Farré D, Núñez O,
Martinez J and Albà MM: PROMO: Detection of known transcription
regulatory elements using species-tailored searches.
Bioinformatics. 18:333–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Farré D, Roset R, Huerta M, Adsuara JE,
Roselló L, Albà MM and Messeguer X: Identification of patterns in
biological sequences at the ALGGEN server: PROMO and MALGEN.
Nucleic Acids Res. 31:3651–3653. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee C and Huang CH: LASAGNA-Search: An
integrated web tool for transcription factor binding site search
and visualization. Biotechniques. 54:141–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kretschmer C, Sterner-Kock A, Siedentopf
F, Schoenegg W, Schlag PM and Kemmner W: Identification of early
molecular markers for breast cancer. Mol Cancer. 10:152011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edgar R, Domrachev M and Lash AE: Gene
expression omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pawitan Y, Bjöhle J, Amler L, Borg AL,
Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, et al: Gene
expression profiling spares early breast cancer patients from
adjuvant therapy: Derived and validated in two population-based
cohorts. Breast Cancer Res. 7:R953–R964. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calabrò A, Beissbarth T, Kuner R, Stojanov
M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka
A and Sültmann H: Effects of infiltrating lymphocytes and estrogen
receptor on gene expression and prognosis in breast cancer. Breast
Cancer Res Treat. 116:69–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Graham TA, Ferkey DM, Mao F, Kimelman D
and Xu W: Tcf4 can specifically recognize beta-catenin using
alternative conformations. Nat Struct Biol. 8:1048–1052. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poy F, Lepourcelet M, Shivdasani RA and
Eck MJ: Structure of a human Tcf4-beta-catenin complex. Nat Struct
Biol. 8:1053–1057. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsuda Y, Schlange T, Oakeley EJ, Boulay
A and Hynes NE: WNT signaling enhances breast cancer cell motility
and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231
xenograft growth. Breast Cancer Res. 11:R322009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mikheev AM, Mikheeva SA, Maxwell JP, Rivo
JV, Rostomily R, Swisshelm K and Zarbl H: Dickkopf-1 mediated tumor
suppression in human breast carcinoma cells. Breast Cancer Res
Treat. 112:263–273. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trifa F, Karray-Chouayekh S, Jmal E, Jmaa
ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J and
Mokdad-Gargouri R: Loss of WIF-1 and Wnt5a expression is related to
aggressiveness of sporadic breast cancer in Tunisian patients.
Tumor Biol. 34:1625–1633. 2013. View Article : Google Scholar
|
|
29
|
Suzuki H, Toyota M, Caraway H, Gabrielson
E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T,
et al: Frequent epigenetic inactivation of Wnt antagonist genes in
breast cancer. Br J Cancer. 98:1147–1156. 2008. View Article : Google Scholar : PubMed/NCBI
|
